STOCK TITAN

Evolent Health (EVH) director Kim Keck granted 41,096 restricted stock units

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

KECK KIM reported acquisition or exercise transactions in this Form 4 filing.

Evolent Health director Kim Keck received an equity grant that increases her direct ownership stake. She was awarded 41,096 shares of Class A Common Stock in the form of restricted stock units under the company’s 2015 Omnibus Incentive Compensation Plan, bringing her direct holdings to 102,597 shares. These units vest on the earlier of June 4, 2027, or the company’s 2027 annual meeting, as long as she continues serving on the board.

Positive

  • None.

Negative

  • None.
Insider KECK KIM
Role null
Type Security Shares Price Value
Grant/Award Class A Common Stock 41,096 $0.00 --
Holdings After Transaction: Class A Common Stock — 102,597 shares (Direct, null)
Footnotes (1)
  1. Represents restricted stock units granted to Ms. Keck pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date.
RSU grant size 41,096 shares Restricted stock units granted to Kim Keck on June 4, 2026
Grant price $0.00 per share Reported grant price for the RSUs
Total shares after grant 102,597 shares Directly owned by Kim Keck following the transaction
Vesting date June 4, 2027 Latest vesting date for the RSUs, or 2027 annual meeting
restricted stock units financial
"Represents restricted stock units granted to Ms. Keck pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Omnibus Incentive Compensation Plan financial
"Represents restricted stock units granted to Ms. Keck pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."
An omnibus incentive compensation plan is a single, flexible program that lets a company grant different kinds of pay — such as cash bonuses, stock options, restricted stock, or performance awards — to employees, executives and directors. Investors care because the plan affects how much ownership can be given away (dilution), how much the company spends on pay, and whether executives’ goals are aligned with shareholders, much like a menu that decides what rewards staff can pick and how costly they are.
vest financial
"Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
beneficially owns financial
"total_shares_following_transaction: 102597.0000, indicating shares the reporting person beneficially owns after the transaction."
Beneficially owns means a person or entity enjoys the economic benefits and control of a security even if the legal title or registration is held in another name. Think of it like having the keys and profits from a car that is registered to a friend: you use it, benefit from it, and make decisions about it even though the official paperwork lists someone else. For investors, this matters because it reveals who truly controls shares, affects voting power, potential conflicts of interest, and regulatory disclosure obligations.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
KECK KIM

(Last)(First)(Middle)
C/O EVOLENT HEALTH, INC.
1812 N. MOORE ST., STE. 1705

(Street)
ARLINGTON VIRGINIA 22209

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Evolent Health, Inc. [ EVH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock(1)06/04/2026A41,096(2)A$0102,597D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents restricted stock units granted to Ms. Keck pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
2. Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date.
Remarks:
/s/ Jonathan Weinberg, Attorney-in-fact06/08/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Evolent Health (EVH) director Kim Keck report in this Form 4?

Kim Keck reported receiving a grant of 41,096 restricted stock units of Evolent Health Class A Common Stock. The award was made under the company’s 2015 Omnibus Incentive Compensation Plan as part of her director compensation, increasing her direct ownership position in the company.

How many Evolent Health (EVH) shares does Kim Keck own after this grant?

After the reported grant, Kim Keck directly beneficially owns 102,597 shares of Evolent Health Class A Common Stock. This total includes the 41,096 restricted stock units awarded in the transaction, reflecting her expanded equity stake as a director of the company.

What are the vesting terms of Kim Keck’s new Evolent Health (EVH) restricted stock units?

The 41,096 restricted stock units vest on the earlier of June 4, 2027, or the date of Evolent Health’s 2027 annual meeting. Vesting is conditioned on Kim Keck’s continued service with the company through the applicable vesting date specified in the grant.

Was Kim Keck’s Evolent Health (EVH) Form 4 transaction a market purchase or sale?

The Form 4 shows a grant or award acquisition, not a market purchase or sale. The 41,096 shares of Class A Common Stock were issued as restricted stock units at a reported price of $0.00 per share under the company’s incentive compensation plan.

Under which plan were Kim Keck’s new Evolent Health (EVH) restricted stock units granted?

The restricted stock units were granted under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. This plan governs equity-based awards, such as restricted stock units, granted to directors and other eligible participants of the company.